Part B Drug Payment Change: Understanding the Implications for Pharma

Amanda Forys and Jennifer Snow recorded a live webinar on March 28, 2016 and provided insights on the Part B Drug Payment Model. They focused on what’s known about the proposed Medicare Part B drug payment model and what the implications are for pharmaceutical manufacturers. Ms. Forys and Ms. Snow also shared strategies on how manufacturers will have to evolve to demonstrate product value.